Liferay Portal up to 7.4.3.36 Object Label cross site scripting
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 4.4 | $0-$5k | 0.00 |
Summary
A vulnerability categorized as problematic has been discovered in Liferay Portal up to 7.4.3.36. Impacted is an unknown function of the component Object Module. Executing a manipulation of the argument Label can lead to cross site scripting. The identification of this vulnerability is CVE-2022-42115. The attack may be launched remotely. There is no exploit available.
Details
A vulnerability classified as problematic was found in Liferay Portal up to 7.4.3.36. This vulnerability affects an unknown functionality of the component Object Module. The manipulation of the argument Label with an unknown input leads to a cross site scripting vulnerability. The CWE definition for the vulnerability is CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. As an impact it is known to affect integrity. CVE summarizes:
Cross-site scripting (XSS) vulnerability in the Object module's edit object details page in Liferay Portal 7.4.3.4 through 7.4.3.36 allows remote attackers to inject arbitrary web script or HTML via a crafted payload injected into the object field's `Label` text field.
The weakness was shared 10/19/2022. The advisory is shared for download at portal.liferay.dev. This vulnerability was named CVE-2022-42115 since 10/03/2022. Successful exploitation requires user interaction by the victim. There are known technical details, but no exploit is available. The MITRE ATT&CK project declares the attack technique as T1059.007.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
VulDB is the best source for vulnerability data and more expert information about this specific topic.
Product
Type
Vendor
Name
Version
- 7.4.3.0
- 7.4.3.1
- 7.4.3.2
- 7.4.3.3
- 7.4.3.4
- 7.4.3.5
- 7.4.3.6
- 7.4.3.7
- 7.4.3.8
- 7.4.3.9
- 7.4.3.10
- 7.4.3.11
- 7.4.3.12
- 7.4.3.13
- 7.4.3.14
- 7.4.3.15
- 7.4.3.16
- 7.4.3.17
- 7.4.3.18
- 7.4.3.19
- 7.4.3.20
- 7.4.3.21
- 7.4.3.22
- 7.4.3.23
- 7.4.3.24
- 7.4.3.25
- 7.4.3.26
- 7.4.3.27
- 7.4.3.28
- 7.4.3.29
- 7.4.3.30
- 7.4.3.31
- 7.4.3.32
- 7.4.3.33
- 7.4.3.34
- 7.4.3.35
- 7.4.3.36
License
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 4.4VulDB Meta Temp Score: 4.4
VulDB Base Score: 3.5
VulDB Temp Score: 3.5
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 5.4
NVD Vector: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
10/03/2022 🔍10/19/2022 🔍
10/19/2022 🔍
05/13/2025 🔍
Sources
Advisory: portal.liferay.devStatus: Confirmed
CVE: CVE-2022-42115 (🔍)
GCVE (CVE): GCVE-0-2022-42115
GCVE (VulDB): GCVE-100-211744
Entry
Created: 10/19/2022 10:53Updated: 05/13/2025 19:11
Changes: 10/19/2022 10:53 (39), 11/18/2022 07:19 (11), 05/13/2025 19:11 (16)
Complete: 🔍
Cache ID: 216::103
VulDB is the best source for vulnerability data and more expert information about this specific topic.
No comments yet. Languages: en.
Please log in to comment.